Submissions from 2020
Can Graft vs. Leukemia Effect Be Uncoupled From Graft vs. Host Disease? An Examination of Proportions, Elizabeth Krieger and Amir Ahmed Toor
Submissions from 2018
Autophagy-deficient breast cancer shows early tumor recurrence and escape from dormancy, Masoud H. Manjili
Determining the Quantitative Principles of T Cell Response to Antigenic Disparity in Stem Cell Transplantation, Ali Salman, Vishal Koparde, Charles E. Hall, Max Jameson-Lee, Catherine Roberts, Myrna Serrano, Badar AbdulRazzaq, Jeremy Meier, Caleb Kennedy, Masoud H. Manjili, Stephen R. Spellman, Dayanjan Wijesinghe, Shahrukh Hashmi, Greg Buck, Rehan Qayyum, Michael Neale, Jason Reed, and Amir A. Toor
Submissions from 2017
Sequence homology between HLA-bound cytomegalovirus and human peptides: A potential trigger for alloreactivity, Charles E. Hall, Vishal N. Koparde, Maximilian Jameson-Lee, Abdelrhman G. Elnasseh, Allison F. Scalora, David J. Kobulnicky, Myrna G. Serrano, Catherine H. Roberts, Gregory A. Buck, Michael C. Neale, Daniel E. Nixon, and Amir A. Toor
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5, John W. Smith, Marc E. Buyse, Priya Rastogi, Charles E. Geyer Jr., Samuel A. Jacobs, Erica J. Patocskai, André Robidoux, Alison K. Conlin, Bilal Ansari, George P. Keogh, Philip J. Stella, Howard M. Gross, Raymond S. Lord, Jonathan A. Polikoff, Celine Mauquoi, Eleftherios P. Mamounas, Sandra M. Swain, and Norman Wolmark
Submissions from 2016
Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells, Kyle K. Payne, Rebecca Keim, Laura Graham, Michael O. Idowu, Wen Wan, Xiang-Yang Wang, Amir A. Toor, Harry D. Bear, and Masoud H. Manjili
Submissions from 2015
Epigenetic Modifications of the PGC-1α Promoter during Exercise Induced Expression in Mice, Timothy L. Lochmann, Ravindar R. Thomas, James P. Bennett, and Shirley M. Taylor
Submissions from 2014
Job attributes, job satisfaction and the return to health after breast cancer diagnosis and treatment, Andrew J. Barnes, Nicholas Robert, and Cathy J. Bradley
Inhibition of the MDM2 E3 Ligase Induces Apoptosis and Autophagy in Wild-Type and Mutant p53 Models of Multiple Myeloma, and Acts Synergistically with ABT-737, Dongmin Gu, Shuhong Wang, Isere Kuiatse, Hua Wang, Jin He, Yun Dai, Richard J. Jones, Chad C. Bjorklund, Jing Yang, Steven Grant, and Robert Z. Orlowski
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer, Olivia Pagani, Meredith M. Regan, Barbara A. Walley, Gini F. Fleming, Marco Colleoni, István Láng, Henry L. Gomez, Carlo Tondini, Harold J. Burstein, Edith A. Perez, Eva Ciruelos, Vered Stearns, Hervé R. Bonnefoi, Silvana Martino, Charles E. Geyer Jr., Graziella Pinotti, Fabio Puglisi, Diana Crivellari, Thomas Ruhstaller, Eric P. Winer, Manuela Rabaglio-Poretti, Rudolf Maibach, Barbara Ruepp, Anita Giobbie-Hurder, Karen N. Price, Jürg Bernhard, Weixiu Luo, Karin Ribi, Giuseppe Viale, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, and Prudence A. Francis
Circumvention of Mcl-1-Dependent Drug Resistance by Simultaneous Chk1 and MEK1/2 Inhibition in Human Multiple Myeloma Cells, Xin-Yan Pei, Yun Dai, Jessica Felthousen, Shuang Shen, Yukie Takabatake, Liang Zhou, Leena E. Youssefian, Michael W. Sanderson, Wesley W. Bodie, Lora B. Kramer, Robert Z. Orlowski, and Steven Grant
Live Cell Interferometry Quantifies Dynamics of Biomass Partitioning during Cytokinesis, Thomas A. Zangle, Michael A. Teitell, and Jason Reed
Submissions from 2013
Peripheral blood mononuclear cells of breast cancer patients can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells [poster abstract], Kyle K. Payne, Christine K. Zoon, Wen Wan, Khin Marlar, Rebecca C. Keim, Mehrab Nasirir Kenari, Latif Kazim, Harry D. Bear, and Masoud H. Manjili
Submissions from 2012
Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors, Claudio Anasetti, Brent R. Logan, Stephanie J. Lee, Edmund K. Waller, Daniel J. Weisdorf, John R. Wingard, Corey S. Cutler, Peter Westervelt, Ann Woolfrey, Stephen Couban, Gerhard Ehninger, Laura Johnston, Richard T. Maziarz, Michael A. Pulsipher, David L. Porter, Shin Mineishi, John M. McCarty, Shakila P. Khan, Paolo Anderlini, William I. Bensinger, Susan F. Leitman, Scott D. Rowley, Christopher Bredeson, Shelly L. Carter, Mary M. Horowitz, and Dennis L. Confer
Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer, Harry D. Bear, Gong Tang, Priya Rastogi, Charles E. Geyer Jr., Andre Robidoux, James N. Atkins, Luis Baez-Diaz, Adam M. Brufsky, Rita S. Mehta, Louis Fehrenbacher, James A. Young, Francis M. Senecal, Rakesh Gaur, Richard G. Margolese, Paul T. Adams, Howard M. Gross, Joseph P. Costantino, Sandra M. Swain, Eleftherios P. Mamounas, and Norman Wolmark
Submissions from 2000
Development of a high throughput, molecular diagnostic assay for predicting telomerase activity in breast cancer cell lines and tissues, L. Elmore, A. Akalin, L. Gollahon, G. Clarke, M. Grimes, A. Ferreira-Gonzalez, C. Garrett, and S. Holt
Submissions from 1991
Efficacy and Cost Effectiveness of Adjuvant Chemotherapy in Women with Node-Negative Breast Cancer — A Decision-Analysis Model, Bruce E. Hillner , M.D. and Thomas J. Smith , M.D.